DeborahPhyllisMerkeMDMS
Pediatric Endocrinology • Bethesda, MDPediatric Bone Metabolism Disorders
Senior Investigator and Chief of Pediatric Services at the NIH Clinical Center
Dr. Merke is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
Nih Clinical Ctr
Building 10 CRC Room 12740
Bethesda, MD 20892Phone+1 301-496-0718Fax+1 301-402-5618
Education & Training
National Institutes of Health Clinical Center/Eunice Kennedy Shriver NICHDFellowship, Pediatric Endocrinology, 1994 - 1997
Children's Hospital of PhiladelphiaResidency, Pediatrics, 1991 - 1994
Jacobs School of Medicine and Biomedical Sciences at the University at BuffaloClass of 1991
Certifications & Licensure
MD State Medical License 1995 - 2025- American Board of Pediatrics Pediatrics
- American Board of Pediatrics Pediatric Endocrinology
Clinical Trials
- Three Drug Combination Therapy Versus Conventional Treatment of Children With Congenital Adrenal Hyperplasia Start of enrollment: 1995 Jun 08
- Natural History Study of Patients With Excess Androgen Start of enrollment: 2006 Jan 02
- Comparison of Cortisol Pump With Standard Treatment for Congenital Adrenal Hyperplasia Start of enrollment: 2013 May 06
Publications & Presentations
PubMed
- 60 citationsUtility of plasma free metanephrines for detecting childhood pheochromocytoma.Martina Weise, Deborah P. Merke, Karel Pacak, McClellan M. Walther, Graeme Eisenhofer
The Journal of Clinical Endocrinology and Metabolism. 2002-05-01 - 867 citationsDiagnosis and Treatment of Primary Adrenal Insufficiency: An Endocrine Society Clinical Practice Guideline.Stefan R. Bornstein, Bruno Allolio, Wiebke Arlt, Andreas Barthel, Andrew C. Don-Wauchope
The Journal of Clinical Endocrinology and Metabolism. 2016-02-01 - 206 citationsModified-Release Hydrocortisone to Provide Circadian Cortisol ProfilesMiguel Debono, Cyrus Ghobadi, Amin Rostami-Hodjegan, Hiep Huatan, Michael J. Campbell
The Journal of Clinical Endocrinology and Metabolism. 2009-05-01
Journal Articles
- Congenital Adrenal Hyperplasia Due to Steroid 21-Hydroxylase Deficiency: An Endocrine Society Clinical Practice GuidelineSharon E Oberfield, Walter L Miller, Perrin C White, Deborah P Merke, Richard J Auchus, The Journal of Clinical Endocrinology and Metabolism
- Long‐Term Use of Continuous Subcutaneous Hydrocortisone Infusion Therapy in Patients with Congenital Adrenal HyperplasiaAshwini Mallappa, Aikaterini A Nella, Deborah P Merke, Clinical Endocrinology
Lectures
- Rethinking Adrenal Androgens in Physiology and DiseaseENDO 2019 - New Orleans, LA - 3/24/2019
- Transition, New Insights into Etiology, and PrescriptionsENDO 2019 - New Orleans, LA - 3/26/2019
- Transition, New Insights into Etiology, and Prescriptions (Repeat)ENDO 2019 - New Orleans, LA - 3/26/2019
- Join now to see all
Other
- Diagnosis of classic congenital adrenal hyperplasia due to 21-hydroxylase deficiencyMerke DP
http://www.uptodate.com/contents/diagnosis-of-classic-congenital-adrenal-hyperplasia-due-to-21-hydro
UpToDate, Wolters Kluwer Health - 2012-08-02 - Genetics and clinical presentation of classic congenital adrenal hyperplasia due to 21-hydroxylase deficiencyMerke DP
http://www.uptodate.com/contents/genetics-and-clinical-presentation-of-classic-congenital-adrenal-hy
UpToDate, Wolters Kluwer Health - 2013-04-04 - Treatment of classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency in infants and childrenMerke DP
http://www.uptodate.com/contents/treatment-of-classic-congenital-adrenal-hyperplasia-due-to-21-hydro
UpToDate, Wolters Kluwer Health - 2012-12-12
Press Mentions
- Tenascin-X—Discovery and Early ResearchJanuary 11th, 2021
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
